Drug intelligence / Profile preview

Technetium Tc-99m pyrophosphate

Development stage
Approved
Lead developer
Mallinckrodt
Modality
Antibody-Radionuclide Conjugates → Antibody Conjugates → Antibody-Based Therapeutics, Gamma Emitters → Radiopharmaceuticals, Small Molecules
Administration
Intravenous
01

Overview

Technetium Tc-99m pyrophosphate is a radiopharmaceutical diagnostic agent used primarily for imaging the bones and heart. It is administered intravenously and accumulates in areas of altered osteogenesis (bone formation) and in injured myocardium, particularly regions with irreversibly damaged myocardial cells. Its main clinical uses are skeletal scintigraphy to detect bone abnormalities (such as metastases or fractures) and cardiac imaging to evaluate acute myocardial infarction by highlighting necrotic tissue. The mechanism of action involves the localization of the radiotracer at sites of increased calcium deposition or cell injury, allowing visualization via gamma camera imaging. It has also been used for noninvasive assessment in amyloidosis and muscle necrosis[1][3][5].

Brand names
Technescan PYP
Other names
technetium tc 99m pyrophosphatestannous pyrophosphate
02

Targets

Hydroxyapatite

Beyond the preview

Go deeper on Technetium Tc-99m pyrophosphate.

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from study design and recruitment through results.

  • Trial phase
  • Status
  • Readouts

Indications & development

Explore development by indication, patient population, and geography.

  • Indications
  • Development status
  • Countries

Licensing & deals

Trace asset ownership, licensing agreements, and commercial partnerships.

  • Partners
  • Deal terms
  • Milestones

Patents & exclusivity

Explore the patent landscape and regulatory exclusivity around an asset.

  • Patents
  • Expiration dates
  • Exclusivity

Competitive landscape

Compare development programs by target, modality, and indication.

  • Competing assets
  • Targets
  • Development stage

Research & analysis

Connect source evidence and development news to your research questions.

  • Publications
  • News
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on Technetium Tc-99m pyrophosphate.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call